Cambridge, United Kingdom

Timothy Holden

USPTO Granted Patents = 4 



Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Haddenham, GB (2015)
  • Cambridge, GB (2016 - 2018)

Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovative Contributions of Timothy Holden

Introduction

Timothy Holden is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in drug substitution therapy. With a total of four patents to his name, Holden's work has the potential to impact the treatment of pain and drug dependency.

Latest Patents

One of Holden's latest patents is the buprenorphine-wafer for drug substitution therapy. This invention relates to oral pharmaceutical dosage forms that comprise buprenorphine, which releases the drug instantly upon oral, preferably sublingual, application. The dosage form is designed for treating pain in both humans and animals, as well as for aiding drug-dependent individuals in their recovery.

Career Highlights

Throughout his career, Timothy Holden has worked with reputable companies in the pharmaceutical industry, including Purdue Pharma L.P. and Rhodes Pharmaceuticals L.P. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Holden has collaborated with several professionals in his field, including Alexander Oksche and William Heath. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Timothy Holden's contributions to pharmaceutical innovations, particularly in drug substitution therapy, highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in treatment options for pain and drug dependency.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…